SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-035495
Filing Date
2023-12-28
Accepted
2023-12-28 16:28:03
Documents
20
Period of Report
2023-12-26
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20231228_8k.htm   iXBRL 8-K 28144
2 EXHIBIT 3.1 ex_610667.htm EX-3.1 5031
7 image01.jpg GRAPHIC 120690
8 image02.jpg GRAPHIC 105376
9 image03.jpg GRAPHIC 212437
10 image04.jpg GRAPHIC 145219
11 image05.jpg GRAPHIC 58381
12 image06.jpg GRAPHIC 154295
  Complete submission text file 0001437749-23-035495.txt   1282219

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20231226.xsd EX-101.SCH 3852
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20231226_def.xml EX-101.DEF 13764
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20231226_lab.xml EX-101.LAB 18089
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20231226_pre.xml EX-101.PRE 13796
14 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20231228_8k_htm.xml XML 4372
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 231522992
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)